Jimenez, MD, a neurologist at Baptist Health Miami Neuroscience Institute, discussed how advancements have changed the landscape of care for patients living with spinal muscular atrophy. The treatment ...
Erika Trovato, DO, MS, program director of the Brain Injury Medicine Fellowship at Burke Rehabilitation Hospital, provided clinical advice for trainees and early-career physicians looking to establish ...
The absence of symptoms, nonserious classification, and generally stable neurodevelopmental assessments support short-term clinical quiescence, but do not define long-term neurologic risk. Uncertain ...
The FDA has granted Fast Track Designation to safusidenib, an investigational oral, brain-penetrant selective inhibitor of mutant IDH1, for the treatment of patients with IDH1-mutant glioma, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results